Core Viewpoint - Halper Sadeh LLC is investigating potential breaches of fiduciary duties by certain officers and directors of DocGo Inc. (NASDAQ: DCGO) towards shareholders [1] Group 1: Legal Actions and Shareholder Rights - Long-term shareholders of DocGo may seek corporate governance reforms, return of funds, court-approved financial incentives, or other benefits [2] - Shareholder involvement is crucial for improving company policies and practices, leading to enhanced shareholder value [3] Group 2: Firm's Background and Services - Halper Sadeh LLC represents global investors affected by securities fraud and corporate misconduct, having recovered millions for defrauded investors [4]

Core Insights - GoodRx Holdings, Inc. reported quarterly earnings of $0.08 per share, missing the Zacks Consensus Estimate of $0.09 per share, representing an earnings surprise of -11.11% [1] - The company posted revenues of $196.03 million for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 1.34% [2] - GoodRx shares have declined approximately 28.8% year-to-date, contrasting with the S&P 500's gain of 16.5% [3] Earnings Performance - Over the last four quarters, GoodRx has not surpassed consensus EPS estimates, with the most recent earnings matching the previous year's figure of $0.08 per share [1][2] - The current consensus EPS estimate for the upcoming quarter is $0.10, with projected revenues of $196.93 million, and for the current fiscal year, the estimate is $0.38 on revenues of $796.43 million [7] Market Outlook - The sustainability of GoodRx's stock price movement will largely depend on management's commentary during the earnings call and future earnings expectations [3][4] - The Zacks Rank for GoodRx is currently 3 (Hold), indicating that shares are expected to perform in line with the market in the near future [6] Industry Context - The Medical Services industry, to which GoodRx belongs, is currently ranked in the bottom 43% of over 250 Zacks industries, suggesting potential challenges ahead [8] - Another company in the same industry, DocGo Inc., is expected to report a quarterly loss of $0.09 per share, reflecting a significant year-over-year decline [9]

1.10月21日(周二)美股盘前，美股三大股指期货涨跌不一。截至发稿，道指期货涨0.08%，标普500指数期货涨0.03%，纳指期货 跌0.05%。 | = US 30 | 46,743.90 | 46,784.30 | 46,618.00 | +37.30 | +0.08% | | --- | --- | --- | --- | --- | --- | | = US 500 | 6.737.30 | 6.747.80 | 6.726.40 | +2.20 | +0.03% | | 트 US Tech 100 | 25,128.60 | 25,204.30 | 25,090.10 | -12.40 | -0.05% | 2.截至发稿，德国DAX指数涨0.17%，英国富时100指数涨0.30%，法国CAC40指数涨0.55%，欧洲斯托克50指数涨0.26%。 | 德国DAX30 | 24,333.47 | 24,342.47 | 24,200.51 | +42.28 | +0.17% | | --- | --- | --- | --- | --- | --- | | 英国富时100 | 9,432.20 | 9 ...

Market Overview - US stock index futures showed mixed movements with Dow futures up 0.08% and S&P 500 futures up 0.03%, while Nasdaq futures fell 0.05% [1] - European indices also experienced gains, with Germany's DAX up 0.17%, UK's FTSE 100 up 0.30%, France's CAC40 up 0.55%, and the Euro Stoxx 50 up 0.26% [2][3] - WTI crude oil rose by 0.79% to $57.47 per barrel, and Brent crude oil increased by 0.67% to $61.42 per barrel [3][4] Market Sentiment - The recent rebound in US stocks is attributed to short covering rather than genuine investor confidence, indicating a potential "false prosperity" [5] - Concerns about the US credit market tightening could lead to forced selling by pension funds, which may trigger a significant market downturn [5] - Allianz's chief economist noted that the current AI investment boom is a "rational bubble" that could help the US outperform global markets [5] Federal Reserve Insights - Wall Street analysts predict that the Federal Reserve may announce the end of its balance sheet reduction plan in the upcoming meeting, which could stabilize monetary policy [6] - Recent market fluctuations have led to increased use of the Fed's repurchase agreement tool, indicating liquidity concerns [6] Individual Company Performance - General Motors (GM) reported Q3 revenue of $48.59 billion, exceeding expectations of $45.26 billion, and raised its full-year EPS guidance to $9.75-$10.50 [7][8] - Coca-Cola (KO) posted Q3 revenue of $12.46 billion, surpassing the expected $12.41 billion, and reaffirmed its 2025 guidance [8] - GE Aerospace's Q3 revenue increased by 24% to $12.18 billion, driven by strong performance in its commercial engine business [8] - Zion Bank's Q3 profit exceeded expectations, with revenue of $872 million, indicating that credit pressure in regional banks may be isolated incidents [8] - DocGo's stock surged nearly 27% following its acquisition of virtual healthcare platform SteadyMD [8] Upcoming Earnings Reports - Notable earnings reports expected include Netflix, Texas Instruments, and Alliance West Bank on Wednesday morning, and Barclays, Teck Resources, and AT&T before market open [10]

Core Viewpoint - DocGo has announced the acquisition of virtual healthcare platform SteadyMD, leading to a significant increase in its stock price, which rose by 48% at one point during pre-market trading [1] Group 1: Acquisition Details - The acquisition will be funded through existing cash on DocGo's balance sheet [1] - SteadyMD is projected to generate approximately $25 million in revenue by 2025, with a positive EBITDA expected in 2026 [1] - Following the acquisition, key executives from SteadyMD, including CEO Guy Friedman and COO Yarone Goren, will join DocGo's leadership team [1] Group 2: Financial Guidance - DocGo plans to update its revenue and adjusted EBITDA guidance for 2025 to reflect the impact of the acquisition during its upcoming earnings report and conference call, scheduled for early November [1]

Group 1: Apple Inc. (AAPL) - Apple is approaching a $4 trillion market cap, with shares rising nearly 4% recently [2] - Strong demand for the iPhone 17 has been noted, with Loop Capital upgrading Apple to Buy and raising the price target to $315 from $226, while Evercore ISI added Apple to its Tactical Outperform List with a $290 price target [3] - The iPhone 17 series has outsold the iPhone 16 series by 14% in its first 10 days, with the base model driving a 33% increase in sell-out data compared to the iPhone 16 [4] Group 2: Unilever (UL) - Unilever is postponing the planned demerger of its ice cream business due to the U.S. government shutdown, which affects the SEC's ability to declare the registration statement effective for the listing [5] - Despite the delay, Unilever will still hold the general meeting of shareholders to vote on the proposed consolidation of its share capital as scheduled [6] Group 3: e.l.f. Beauty (ELF) - e.l.f. Beauty shares fell nearly 7% after reporting disappointing sales of rhode beauty, totaling $40.2 million for the quarter ending June 30, which was below investor expectations [7] - Analysts had projected that the $1 billion acquisition of rhode would add approximately $0.38 to FY25 earnings, but this may be reduced due to uncertain tariff conditions and recent disclosures [8]

Core Insights - Crown Holdings Inc reported better-than-expected third-quarter financial results, with adjusted earnings of $2.24 per share, surpassing the analyst estimate of $2 [1] - The company's quarterly revenue reached $3.2 billion, exceeding the Street estimate of $3.12 billion [1] - Following the positive earnings report, Crown Holdings shares increased by 8.6% to $102.52 in pre-market trading [1] Financial Performance - Adjusted earnings per share (EPS) for the third quarter were $2.24, beating the expected $2 [1] - Quarterly revenue was reported at $3.2 billion, higher than the anticipated $3.12 billion [1] - The company raised its FY25 adjusted EPS guidance, indicating positive future expectations [1]

This quarterly report represents an earnings surprise of 16.67%. A quarter ago, it was expected that this company would post a loss of $0.23 per share when it actually produced a loss of $0.25, delivering a surprise of -8.70%. Sera Prognostics, Inc. (SERA) came out with a quarterly loss of $0.20 per share versus the Zacks Consensus Estimate of a loss of $0.24. This compares to loss of $0.25 per share a year ago. These figures are adjusted for non-recurring items. There are no easy answers to this key questi ...

Core Insights - Kahn Swick & Foti, LLC (KSF) is investigating DocGo Inc. following allegations of misrepresentation regarding its contracts and executive conduct [1][2] - DocGo's contract with U.S. Customs and Border Protection (CBP) was reported to be worth under $2 billion, contrary to the company's claim of $4 billion [2] - The CEO of DocGo resigned due to fabricated elements of his educational background [2] - A securities class action lawsuit has been filed against DocGo and its executives for failing to disclose material information and violating federal securities laws [3] - The court has denied DocGo's motion to dismiss the lawsuit, allowing it to proceed [3] - KSF's investigation is focused on potential breaches of fiduciary duties by DocGo's officers and directors [3] Company Overview - DocGo is a healthcare company that provides medical transportation and mobile health services in the U.S. and the U.K. [2] - The company is currently facing legal challenges due to allegations of corporate misconduct [3] Legal Context - KSF is a prominent securities litigation law firm, ranked among the top 10 firms nationally based on total settlement value [4] - The firm is seeking information from individuals who may assist in the investigation or have been long-term holders of DocGo shares [4]